← Back to all trials
Recruiting
NCT05152368
Safety of Cultured Allogeneic Adult Umbilical Cordor Placental Derived Stem Cells Exosomes for Trigeminal Neuralgia
Conditions: Peripheral Neuropathy, Trigeminal Neuralgia
Sex: All
Healthy volunteers: No
Phase: PHASE1
Enrollment: 20
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Location: Prodromos Stem Cell Institute Naples Florida
Summary
This trial will study the safety and efficacy of instillation of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes for the treatment of Trigeminal Neuralgia.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Trigeminal Neuralgia or Peripheral Neuropathy
* Understanding and willingness to sign a written informed consent document
Exclusion Criteria:
* Active infection
* Active cancer
* Chronic multisystem organ failure
* Pregnancy
* Clinically significant Abnormalities on pre-treatment laboratory evaluation
* Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
* Continued drug abuse
* Pre-menopausal women not using contraception
* Previous organ transplant
* Hypersensitivity to sulfur
Source: ClinicalTrials.gov (NCT05152368). StuddyBuddy aggregates publicly available trial information.